Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP964483.RA3i2XgmUUvSkRftYWlOQvDy2200lR7gTfnvS0C-HezUE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP964483.RA3i2XgmUUvSkRftYWlOQvDy2200lR7gTfnvS0C-HezUE130_assertion type Assertion NP964483.RA3i2XgmUUvSkRftYWlOQvDy2200lR7gTfnvS0C-HezUE130_head.
- NP964483.RA3i2XgmUUvSkRftYWlOQvDy2200lR7gTfnvS0C-HezUE130_assertion description "[Expression of ER?1, ER?2, ER?5 and five further variants was associated with the oncogenes MYBL2 or HER2 in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964483.RA3i2XgmUUvSkRftYWlOQvDy2200lR7gTfnvS0C-HezUE130_provenance.
- NP964483.RA3i2XgmUUvSkRftYWlOQvDy2200lR7gTfnvS0C-HezUE130_assertion evidence source_evidence_literature NP964483.RA3i2XgmUUvSkRftYWlOQvDy2200lR7gTfnvS0C-HezUE130_provenance.
- NP964483.RA3i2XgmUUvSkRftYWlOQvDy2200lR7gTfnvS0C-HezUE130_assertion SIO_000772 22378275 NP964483.RA3i2XgmUUvSkRftYWlOQvDy2200lR7gTfnvS0C-HezUE130_provenance.
- NP964483.RA3i2XgmUUvSkRftYWlOQvDy2200lR7gTfnvS0C-HezUE130_assertion wasDerivedFrom befree-2016 NP964483.RA3i2XgmUUvSkRftYWlOQvDy2200lR7gTfnvS0C-HezUE130_provenance.
- NP964483.RA3i2XgmUUvSkRftYWlOQvDy2200lR7gTfnvS0C-HezUE130_assertion wasGeneratedBy ECO_0000203 NP964483.RA3i2XgmUUvSkRftYWlOQvDy2200lR7gTfnvS0C-HezUE130_provenance.